Молимо вас користите овај идентификатор за цитирање или овај линк до ове ставке:
https://scidar.kg.ac.rs/handle/123456789/9355
Назив: | Recent developments in the world’s leading generic markets |
Аутори: | Jakovljevic, Mihajlo |
Датум издавања: | 2014 |
Сажетак: | © 2014, Serbian Medical Society . All rights reserved. Possible net savings achieved via generic substitution of brand name drugs within the EU healthcare expenditure amount to € 30 billion. In the course of the past 5 years, some of the leading therapy classes, such as oncologics, antihypertensive, antidiabetics, lipid regulators, antipsychotics, platelet aggregation inhibitors, antiulcerants and a few others, experienced fierce generic competition, when blockbuster patents expired. This review aims to describe contemporary circumstances within the leading global generic markets. |
URI: | https://scidar.kg.ac.rs/handle/123456789/9355 |
Тип: | article |
DOI: | 10.5937/mckg48-5071 |
ISSN: | 0350-1221 |
SCOPUS: | 2-s2.0-84943607983 |
Налази се у колекцијама: | Faculty of Medical Sciences, Kragujevac |
Датотеке у овој ставци:
Датотека | Опис | Величина | Формат | |
---|---|---|---|---|
10.5937-mckg48-5071.pdf | 137.66 kB | Adobe PDF | Погледајте |
Ова ставка је заштићена лиценцом Креативне заједнице